செயல்படுத்தல் வழிகாட்டல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செயல்படுத்தல் வழிகாட்டல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செயல்படுத்தல் வழிகாட்டல் Today - Breaking & Trending Today

American Journal of Psychiatry Publishes International Ketamine and Esketamine Treatment Guidance Led by Braxia Scientific CEO Dr. Roger Mcintyre


Share this article
Share this article
International Expert Opinion and Implementation Guidance outlines Ketamine and Esketamine treatment parameters setting the standard for the clinical implementation of these rapid-acting treatments in treatment resistant depression
Guidance published in the official Journal of the American Psychiatric Association establishes Braxia Scientific as an international leader in the rapidly evolving industry of Ketamine, Esketamine and rapid acting antidepressants
TORONTO, June 9, 2021 /PRNewswire/ - Braxia Scientific Corp. ( Braxia , or the Company ), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company with clinics  providing novel ketamine treatments for persons with depression and related disorders, is pleased to announce the American Journal of Psychiatry, the most widely read psychiatric journal in the world, has published the International Expert Opinion and Implementation Guidance (the Guidelines ) for the clini ....

United States , Rogers Mcintyre , Joshua Rosenblat , Braxia Health , Braxia Scientific Corp , Excellence Inc , International Expert Opinion , Journal Of The American Psychiatric Association , Canadian Rapid Treatment Center , Implementation Guidance , American Psychiatric Association , Braxia Scientific , American Journal , Braxia Health Medical Director , Expert Opinion , Treatment Resistant Depression , Available Evidence , Restated Listing Statement , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries , ஒன்றுபட்டது மாநிலங்களில் , ரோஜர்ஸ் முசந்த்ிரே , சிறப்பானது இன்க் , இதழ் ஆஃப் தி அமெரிக்கன் மனநல சங்கம் , கனடியன் விரைவான சிகிச்சை மையம் ,

Braxia Scientific Corp team-led guidelines into clinical uses of ketamine and esketamine published in prestigious American Journal of Psychiatry


Braxia Scientific team-led guidelines into clinical uses of ketamine and esketamine published in prestigious American Journal of Psychiatry
Its CEO Roger McIntyre and medical director Joshua Rosenblat led a team of experts to develop the International Expert Opinion and Implementation Guidance for the clinical use of rapid-acting ketamine and esketamine for treatment-resistant depression
Esketamine therapy received FDA approval with breakthrough status in 2019
Braxia Scientific Corp (CSE:BRAX) (OTCMKTS:BRAXF) (FRA:496) CEO Roger McIntyre saw his research into the clinical uses of ketamine and esketamine published in the prestigious American Journal of Psychiatry. 
McIntyre and Braxia’s medical director Joshua Rosenblat led a team of 26 experts to develop the International Expert Opinion and Implementation Guidance (Guidelines) for the clinical use of rapid-acting Ketamine and Esketamine for treatment-resistant depression, according to Braxia.  ....

United States , Roger Mcintyre , Joshua Rosenblat , Braxia Scientific Corp , International Expert Opinion , American Journal , Implementation Guidance , Treatment Resistant Depression , Expert Opinion , Braxia Scientific Corp , Nsx Brax , ஒன்றுபட்டது மாநிலங்களில் , ரோஜர் முசந்த்ிரே , அமெரிக்கன் இதழ் , செயல்படுத்தல் வழிகாட்டல் , சிகிச்சை எதிர்ப்பு மனச்சோர்வு , நிபுணர் கருத்து ,